Citation Impact
Citing Papers
The Potential Role of Curcumin in Patients with Monoclonal Gammopathy of Undefined Significance—Its Effect on Paraproteinemia and the Urinary N-Telopeptide of Type I Collagen Bone Turnover Marker
2009
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Autophagy, cell death, and cancer
2015
A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis
2003
Group‐specific primer and probe sets to detect methanogenic communities using quantitative real‐time polymerase chain reaction
2005 Standout
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
Honokiol produces anti‐neoplastic effects on melanoma cells in vitro
2011
Bortezomib inhibits human osteoclastogenesis
2007
4-Hydroxynonenal and PPARγ ligands affect proliferation, differentiation, and apoptosis in colon cancer cells
2007
Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell Us
2002
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced‐dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients
2002
Therapeutic applications of compounds in the Magnolia family
2011 Standout
BSc2118 is a novel proteasome inhibitor with activity against multiple myeloma
2010
Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow
2013
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
AspergillusPolymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing
2015
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
2005
Response Rate, Durability of Response, and Survival After Thalidomide Therapy for Relapsed Multiple Myeloma
2003
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Cancer stem cells revisited
2017 Standout
Short-Chain Fatty Acids Induce Apoptosis in Colon Cancer Cells Associated with Changes to Intracellular Redox State and Glucose Metabolism
2012
Liposome: classification, preparation, and applications
2013 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
2012
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Prevalence and clinical significance of anticardiolipin and anti‐β2‐glycoprotein‐I antibodies in patients with non‐Hodgkin's lymphoma
2002
Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function
2005
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits
2000
Systemic amyloidosis
2015 Standout
Early Detection ofAspergillusInfection after Allogeneic Stem Cell Transplantation by Polymerase Chain Reaction Screening
2000
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials
2001
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment
2004
Review: Amyloidogenesis—Unquestioned Answers and Unanswered Questions
2000
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Multiple myeloma: evolving genetic events and host interactions
2002
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine
2014
Mucormycosis in systemic lupus erythematosus
2003
Histone deacetylase inhibitors in clinical development
2004
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literature
2003
Use of Real‐Time PCR on Blood Samples for Diagnosis of Invasive Aspergillosis
2001
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Mechanisms of apoptosis induction by nucleoside analogs
2003
A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays
2002
Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center
2011
The potential of proteasome inhibitors in cancer therapy
2008
Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor
2004
Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
2001
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy
2012 Standout
Molecular Mechanisms of Amyloidosis
2003 Standout
Accuracy of BAL Galactomannan in Diagnosing Invasive Aspergillosis
2010
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Tumorigenesis and the angiogenic switch
2003 Standout
Matrix metalloproteinases and tumor metastasis
2006 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Liposomal encapsulated anti-cancer drugs
2005
Comparison of Non-Culture-Based Methods for Detection of Systemic Fungal Infections, with an Emphasis on Invasive Candida Infections
2005
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
A Study to Determine the Effects of Food and Multiple Dosing on the Pharmacokinetics of Vorinostat Given Orally to Patients with Advanced Cancer
2006
Magnolol-based bio-epoxy resin with acceptable glass transition temperature, processability and flame retardancy
2020 Standout
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Differentiation therapy of leukemia: 3 decades of development
2009
Laboratory diagnosis of invasive candidiasis.
2005
Laboratory diagnosis of invasive aspergillosis
2005
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens
2011
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors
2010
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Autologous stem cell transplantation for primary systemic amyloidosis
2002
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
2013
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.
2001
Honokiol: A Review of Its Anticancer Potential and Mechanisms
2019
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Rapid Detection and Identification ofCandida,Aspergillus, andFusariumSpecies in Ocular Samples Using Nested PCR
2000
Neuro‐ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature
2012
Guidelines for Treatment of Candidiasis
2004 Standout
Multiple Myeloma
2011 Standout
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
2002 Standout
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Real-Time PCR Coupled with Automated DNA Extraction and Detection of Galactomannan Antigen in Serum by Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis
2002
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
2004
Works of Jan Eucker being referenced
Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography.
2003
Therapeutic implication of BAL in patients with neutropenia
2009
Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support
1999
Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion
2003
Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma
2001
Disseminated Mucormycosis Caused by Absidia corymbifera Leading to Cerebral Vasculitis
2000
Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma
2005
Rapid and simple differentiation of C. dubliniensis from C. albicans
2004
Liposomal daunorubicin (DaunoXome) in multiple myeloma: a modified VAD regimen using short-term infusion
2003
New therapeutic approaches in primary systemic AL amyloidosis
2000
Arterial thrombosis associated with anticardiolipin and anti‐β2‐glycoprotein‐Iantibodies in patients with non‐Hodgkin's lymphoma: a report of two cases
2000
The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkinʼs lymphomas
2002
Bone resorption parameters [carboxy‐terminal telopeptide of type‐I collagen (ICTP), amino‐terminal collagen type‐I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma
2002
Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma
2000
Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer
2008
Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma
2006
The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions
2013
Novel approaches to the treatment of primary amyloidosis
2000
Mucormycoses
2001
Dual PPARα/γ Ligand TZD18 Either Alone or in Combination with Imatinib Inhibits Proliferation and Induces Apoptosis of Human CML Cell Lines
2006
Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.
2003
Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
2012
Contaminations Occurring in Fungal PCR Assays
1999
Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma
2001
Diagnosis and treatment of AL amyloidosis.
2000
Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy
2001